Page 11 - Data Presented News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022

Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesGina cestariEvan dickLaine yonkerJoseph ruckerAntonio dassoroLauryn wernerExchange commissionUniversity of kansasAmerican association for cancer researchCompany nasdaqEdison groupContext therapeutics incContext therapeuticsAmerican associationCancer research

Chemomab Reports on Two Scientific Presentations that Support the Potential Therapeutic Utility of CM-101 in Systemic Sclerosis

Translational Study Data Presented at 7th Systemic Sclerosis World Congress Confirms CCL24 is Elevated in Diffuse Cutaneous Systemic Sclerosis Patients; High.

Irina kofflerBarbara lindheimWadi morLifesci advisorsScleroderma programme at leeds universitySystemic sclerosis world congressChemomab therapeutics ltdInternational rheumatology conferenceStrategic communicationsPrnewswire chemomab therapeutics ltdSystemic sclerosis world congress confirmsUniversity of leedsTranslational studyData presentedDiffuse cutaneous systemic sclerosis patientsGreater disease activity

Chemomab Reports on Two Scientific Presentations that Support the Potential Therapeutic Utility of CM-101 in Systemic Sclerosis

Translational Study Data Presented at 7th Systemic Sclerosis World Congress Confirms CCL24 is Elevated in Diffuse Cutaneous Systemic Sclerosis Patients; High.

Irina kofflerBarbara lindheimWadi morLifesci advisorsScleroderma programme at leeds universitySystemic sclerosis world congressChemomab therapeutics ltdInternational rheumatology conferenceStrategic communicationsPrnewswire chemomab therapeutics ltdSystemic sclerosis world congress confirmsUniversity of leedsTranslational studyData presentedDiffuse cutaneous systemic sclerosis patientsGreater disease activity

Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: HMPL-523 Clinical Data Presented at ASH

Investegate announcements from Hutchmed China Ltd, HMPL-523 Clinical Data Presented at ASH

United statesGeorgia world congress centerHong kongMark leeZhou yiAtholl tweedie freddy crossleyBen atwell alex shawRenchi yangAnnie chengStock exchange of hong kongUniversity of texas md anderson cancer centerChina limitedExchange commissionAmerican society for hematologyData presentedFlorham park

HUTCHMED Highlights HMPL-523 Clinical Data Presented at the 2021 ASH Annual Meeting

14.12.2021 - HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Dec. 14, 2021 (GLOBE NEWSWIRE) - HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces new analyses on the ongoing studies of HMPL-523 presented at the 63rd American . Seite 1

United statesGeorgia world congress centerRenchi yangChina limitedAmerican society for hematologyData presentedAmerican societyAnnual meetingPreliminary efficacyAdult patientsPrimary immune thrombocytopeniaHematology hospitalChinese academyMedical sciencesPlatelet numberImmune thrombocytopenia